Avindra Nath

Last updated

Avindra "Avi" Nath (born December 1, 1958), is a physician-scientist who specializes in neuroimmunology. Nath is a senior investigator, and intramural clinical director of the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (NIH) in the United States. [1] [2] [3] At NINDS, Nath also leads the Section of Infections of the Nervous System and plans to institute a translational research center. [1] He previously served in several research and administrative positions at the Johns Hopkins Hospital and the Johns Hopkins University School of Medicine.

Contents

As a researcher, Nath investigates the molecular mechanisms whereby human immunodeficiency virus (HIV) causes neurological disorders including HIV dementia. Nath has published over 400 scientific articles, reviews, and book chapters, and is on the editorial board of several journals. He has been an expert advisor to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA). [4] [5] [6]

Training and career

Born in Saskatoon, Saskatchewan; Nath attended Christian Medical College, Ludhiana in Punjab, India. [4] After receiving his medical degree, Nath performed graduate work in neuroscience at the University of Texas Medical Branch (UTMB) in Galveston, Texas.

Nath performed a residency in neurology at the University of Texas Health Science Center in Houston, Texas. He subsequently completed a neuroimmunology research fellowship with J.S. Wolinsky, also in Houston. From 1988 through mid-1990, Nath was a visiting associate at the National Institute of Neurological Disorders and Stroke (NINDS) of the NIH. There, he conducted research with Eugene O. Major and M.E. Dubois-Dalcq. [5]

Nath began his first faculty position in June, 1990, at the University of Manitoba in Canada, where he was promoted from assistant to associate professor and led the research group on neurovirology and neurodegenerative diseases. Nath moved to the University of Kentucky in September, 1997, as a member of the Department of Neurology and the Department of Microbiology and Immunology. While at the University of Kentucky, Nath achieved tenure. In 2002, Nath assumed a professorship at the Johns Hopkins University School of Medicine. [5] [4] There, he held appointments in the Department of Neurology and the Solomon H. Snyder Department of Neuroscience; he also became director of the Division of Neuroimmunology and Neurological Infections. Nath and his laboratory moved to the National Institutes of Health in 2011.

Nath has served as a staff neurologist in Manitoba; Lexington, Kentucky; and at the Johns Hopkins Hospital. [5] [4]

Research

Nath researches the effects of HIV and other infectious agents on the central nervous system.

Notable Contributions

Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is characterized by the selective loss of motor neurons. In a 2015 paper in Science Translational Medicine , Nath and colleagues proposed the controversial hypothesis that endogenous retroviruses may play a causal role in a subset of ALS cases. [7] [8] [9]

Nodding Syndrome

Nodding syndrome is a form of epilepsy endemic in sub-Saharan Africa. [10] The cause of the disease remains unknown, however epidemiologic studies identified an association between nodding syndrome and river blindness, a disease caused by the parasitic worm Onchocerca volvulus . In a 2017 publication in the journal Science Translational Medicine , Dr. Nath and colleagues implicated an autoimmune reaction to O. volvulus as a potential cause of the disease. [11] [12] [13]

Honors

In 2012, Nath was presented with the Pioneer in NeuroVirology Award by the International Society for NeuroVirology (ISNV) at the 11th International Symposium on NeuroVirology held in New York, New York, USA. In 2023, he was invited to deliver the fourth Sharwaree Gokhale Memorial Lecture at the Indian Institute of Science. [14]

Related Research Articles

<span class="mw-page-title-main">National Institutes of Health</span> US government medical research agency

The National Institutes of Health, commonly referred to as NIH, is the primary agency of the United States government responsible for biomedical and public health research. It was founded in the late 1880s and is now part of the United States Department of Health and Human Services. Many NIH facilities are located in Bethesda, Maryland, and other nearby suburbs of the Washington metropolitan area, with other primary facilities in the Research Triangle Park in North Carolina and smaller satellite facilities located around the United States. The NIH conducts its own scientific research through the NIH Intramural Research Program (IRP) and provides major biomedical research funding to non-NIH research facilities through its Extramural Research Program.

<span class="mw-page-title-main">National Institute of Neurological Disorders and Stroke</span> Department of the U.S. National Institutes of Health

The National Institute of Neurological Disorders and Stroke (NINDS) is a part of the U.S. National Institutes of Health (NIH). It conducts and funds research on brain and nervous system disorders and has a budget of just over US$2.03 billion. The mission of NINDS is "to reduce the burden of neurological disease—a burden borne by every age group, every segment of society, and people all over the world". NINDS has established two major branches for research: an extramural branch that funds studies outside the NIH, and an intramural branch that funds research inside the NIH. Most of NINDS' budget goes to fund extramural research. NINDS' basic science research focuses on studies of the fundamental biology of the brain and nervous system, genetics, neurodegeneration, learning and memory, motor control, brain repair, and synapses. NINDS also funds clinical research related to diseases and disorders of the brain and nervous system, e.g. AIDS, Alzheimer's disease, epilepsy, muscular dystrophy, multiple sclerosis, Parkinson's disease, spinal cord injury, stroke, and traumatic brain injury.

The National Institute of Allergy and Infectious Diseases is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Neuroimmunology is a field combining neuroscience, the study of the nervous system, and immunology, the study of the immune system. Neuroimmunologists seek to better understand the interactions of these two complex systems during development, homeostasis, and response to injuries. A long-term goal of this rapidly developing research area is to further develop our understanding of the pathology of certain neurological diseases, some of which have no clear etiology. In doing so, neuroimmunology contributes to development of new pharmacological treatments for several neurological conditions. Many types of interactions involve both the nervous and immune systems including the physiological functioning of the two systems in health and disease, malfunction of either and or both systems that leads to disorders, and the physical, chemical, and environmental stressors that affect the two systems on a daily basis.

<span class="mw-page-title-main">Nodding disease</span> Medical condition

Nodding disease is a disease which emerged in Sudan in the 1960s. It is a mentally and physically disabling disease that only affects children, typically between the ages of 5 and 15. It is currently restricted to small regions in South Sudan, Tanzania, and northern Uganda. Prior to the South Sudan outbreaks and subsequent limited spread, the disease was first described in 1962 existing in secluded mountainous regions of Tanzania, although the connection between that disease and nodding syndrome was only made recently.

<span class="mw-page-title-main">Eva Feldman</span> American neurologist

Eva Lucille Feldman is an American physician-scientist who is a leading authority on neurodegenerative disease. She serves as the Russell N. DeJong Professor of Neurology at the University of Michigan, as well as Director of the NeuroNetwork for Emerging Therapies and ALS Center of Excellence at Michigan Medicine. She was also named the James W. Albers Distinguished University Professor of Neurology.

<span class="mw-page-title-main">Robert B. Darnell</span> American biochemist (born 1957)

Robert Bernard Darnell is an American neurooncologist and neuroscientist, founding director and former CEO of the New York Genome Center, the Robert and Harriet Heilbrunn Professor of Cancer Biology at The Rockefeller University, and an Investigator of the Howard Hughes Medical Institute. His research into rare autoimmune brain diseases led to the invention of the HITS-CLIP method to study RNA regulation, and he is developing ways to explore the regulatory portions—known as the "dark matter"—of the human genome.

<span class="mw-page-title-main">Gerald Fischbach</span> American physician and neuroscientist (born 1938)

Gerald D. Fischbach is an American neuroscientist. He received his M.D. from the Weill Cornell Medical College of Cornell University in 1965 before beginning his research career at the National Institutes of Health in 1966, where his research focused on the mechanisms of neuromuscular junctions. After his tenure at the National Institutes of Health, Fischbach was a professor at Harvard University Medical School from 1972 to 1981 and from 1990 to 1998 and the Washington University School of Medicine from 1981 to 1990. In 1998, he was named the director of the National Institute of Neurological Disorders and Stroke before becoming the Vice President and Dean of the Health and Biomedical Sciences, the Dean of the Faculty of Medicine, and the Dean of the Faculty of Health Sciences at Columbia University from 2001 to 2006. Gerald Fischbach currently serves as the scientific director overseeing the Simons Foundation Autism Research Initiative. Throughout Fischbach's career, much of his research has focused on the formation and function of the neuromuscular junction, which stemmed from his innovative use of cell culture to study synaptic mechanisms.

Neurovirology is an interdisciplinary field which represents a melding of clinical neuroscience, virology, immunology, and molecular biology. The main focus of the field is to study viruses capable of infecting the nervous system. In addition to this, the field studies the use of viruses to trace neuroanatomical pathways, for gene therapy, and to eliminate detrimental populations of neural cells.

Eugene O. "Gene" Major is a senior investigator at the National Institute of Neurological Disorders and Stroke (NINDS), a part of the United States National Institutes of Health (NIH). Major conducts research into the neurological diseases including progressive multifocal leukoencephalopathy (PML), caused by JC virus and often found in immunosuppressed patients such as those with HIV/AIDS. Major has published over 140 scientific articles and reviews in the peer-reviewed literature and has contributed to Fields Virology, a standard virology textbook.

<span class="mw-page-title-main">Gladstone Institutes</span>

Gladstone Institutes is an independent, non-profit biomedical research organization whose focus is to better understand, prevent, treat and cure cardiovascular, viral and neurological conditions such as heart failure, HIV/AIDS and Alzheimer's disease. Its researchers study these diseases using techniques of basic and translational science. Another focus at Gladstone is building on the development of induced pluripotent stem cell technology by one of its investigators, 2012 Nobel Laureate Shinya Yamanaka, to improve drug discovery, personalized medicine and tissue regeneration.

<span class="mw-page-title-main">Huda Zoghbi</span> Lebanese scientist

Huda Yahya Zoghbi, born Huda El-Hibri, is a Lebanese-born American geneticist, and a professor at the Departments of Molecular and Human Genetics, Neuroscience and Neurology at the Baylor College of Medicine. She is the director of the Jan and Dan Duncan Neurological Research Institute. She became the editor of the Annual Review of Neuroscience as of 2018.

<span class="mw-page-title-main">NIH Intramural Research Program</span> Internal research program of the National Institutes of Health

The NIH Intramural Research Program (IRP) is the internal research program of the National Institutes of Health (NIH), known for its synergistic approach to biomedical science. With 1,200 Principal Investigators and over 4,000 Postdoctoral Fellows conducting basic, translational, and clinical research, the NIH Intramural Research Program is the largest biomedical research institution on earth. The unique funding environment of the IRP facilitates opportunities to conduct both long-term and high-impact science that would otherwise be difficult to undertake. With rigorous external reviews ensuring that only the most outstanding research secures funding, the IRP is responsible for many scientific accomplishments, including the discovery of fluoride to prevent tooth decay, the use of lithium to manage bipolar disorder, and the creation of vaccines against hepatitis, Hemophilus influenzae (Hib), and human papillomavirus (HPV). In addition, the IRP has also produced or trained 21 Nobel Prize-winning scientists.

Joseph R. Berger is an American internist and neurologist who is known for his research interests in progressive multifocal leukoencephalopathy (PML), the neurological complications of HIV/AIDS, multiple sclerosis, and other inflammatory disorders of the brain. Particularly, he contributed research on why PML occurs more frequently in AIDS than in other immunosuppressive conditions.

The International Society for NeuroVirology (ISNV) was founded to promote research into disease-causing viruses that infect the human brain and nervous system. The ISNV membership includes scientists and clinicians from around the world who work in the fields of basic, translational, and clinical neurovirology.

Igor Koralnik is an American physician, neurologist and scientist. He is one of the first physicians to study the neurologic complications caused by the human immunodeficiency virus (HIV) and is a leading researcher in the investigation of the polyomavirus JC, which causes progressive multifocal leukoencephalopathy (PML), a disease of the central nervous system that occurs in immunosuppressed individuals.

<span class="mw-page-title-main">Amanda M. Brown</span> American immunologist and microbiologist

Amanda Brown is an American immunologist and microbiologist as well as an associate professor of neurology and neuroscience at Johns Hopkins University School of Medicine in Baltimore, Maryland. Brown is notable for cloning one of the first recombinant HIV viruses and developing a novel method to visualize HIV infected cells using GFP fluorescence.

Howard E. Gendelman is an American physician-scientist whose research intersects the disciplines of neuroimmunology, pharmacology, and infectious diseases. Gendelman was born in Philadelphia, Pennsylvania. His research is focused on harnessing immune responses for therapeutic gain in HIV/AIDS and Neurodegenerative disease. He is the Margaret R. Larson Professor of infectious diseases and internal medicine at the University of Nebraska Medical Center (UNMC) in Omaha.

<span class="mw-page-title-main">Judith R. Walters</span> American neuropharmacologist

Judith Richmond Walters is an American neuropharmacologist serving as chief of the neurophysiological pharmacology section at the National Institute of Neurological Disorders and Stroke.

<span class="mw-page-title-main">Karen Berman</span> American psychiatrist and physician-scientist

Karen Faith Berman is an American psychiatrist and physician-scientist who is a senior investigator and chief of the section on integrative neuroimaging, the psychosis and cognitive studies section, and the clinical and translational neuroscience branch of the National Institute of Mental Health's division of intramural research.

References

  1. 1 2 NINDS Names New Clinical Director, Dr. Avindra Nath
  2. "Principal Investigators : Avindra Nath". NIH Intramural Research Program. Retrieved 2022-07-22.
  3. "Avindra Nath, M.D. | NINDS Division of Intramural Research". research.ninds.nih.gov. Retrieved 2022-07-22.
  4. 1 2 3 4 Neurologists & Neurosurgeons at Johns Hopkins--Profile: Dr. Avindra Nath Archived February 17, 2010, at the Wayback Machine
  5. 1 2 3 4 Nath's curriculum vitae Archived April 1, 2012, at the Wayback Machine
  6. Neuroscience homepage
  7. Li, W; Lee, MH; Henderson, L; Tyagi, R; Bachani, M; Steiner, J; Campanac, E; Hoffman, DA; von Geldern, G; Johnson, K; Maric, D; Morris, HD; Lentz, M; Pak, K; Mammen, A; Ostrow, L; Rothstein, J; Nath, A (30 September 2015). "Human endogenous retrovirus-K contributes to motor neuron disease". Science Translational Medicine. 7 (307): 307ra153. doi:10.1126/scitranslmed.aac8201. PMC   6344353 . PMID   26424568.
  8. Costandi, Mo (30 September 2015). "Dormant viruses may cause motor neuron disease when awoken". The Guardian. Retrieved 27 December 2019.
  9. "Ancient Virus May Cause ALS, Study Finds". NBC News. October 2015.
  10. "Nodding Syndrome". World Health Organization - Control of Neglected Tropical Diseases. Retrieved 22 July 2022.[ title missing ]
  11. "Scientists May Have Solved the Mystery of Nodding Syndrome". NPR .
  12. "Mystery nodding syndrome may be triggered by parasitic worm". 2017-02-15.
  13. Johnson, Tory P.; Tyagi, Richa; Lee, Paul R.; Lee, Myoung-Hwa; Johnson, Kory R.; Kowalak, Jeffrey; Elkahloun, Abdel; Medynets, Marie; Hategan, Alina; Kubofcik, Joseph; Sejvar, James; Ratto, Jeffrey; Bunga, Sudhir; Makumbi, Issa; Aceng, Jane R.; Nutman, Thomas B.; Dowell, Scott F.; Nath, Avindra (2017). "Nodding syndrome may be an autoimmune reaction to the parasitic worm Onchocerca volvulus". Science Translational Medicine. 9 (377): eaaf6953. doi:10.1126/scitranslmed.aaf6953. PMC   5434766 . PMID   28202777.
  14. "Sharwaree Gokhale Memorial Lecture by Dr. Avindra Nath". Indian Institute of Science.

PubMed search for Avindra Nath

Avindra Nath at ResearchGate